Chemical Formula: C36H62O8

Chemical Formula C36H62O8

Found 193 metabolite its formula value is C36H62O8

(20R)-Ginsenoside Rh2

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(20S)-ginsenoside Rh2 is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite, an antineoplastic agent, an apoptosis inducer, a cardioprotective agent, a bone density conservation agent and a hepatoprotective agent. It is a beta-D-glucoside, a 12beta-hydroxy steroid, a ginsenoside, a tetracyclic triterpenoid and a 20-hydroxy steroid. It derives from a hydride of a dammarane. Ginsenoside Rh2 is a natural product found in Panax ginseng and Panax notoginseng with data available. A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

Ginsenoside K

(2s,3r,4s,5s,6r)-2-[(2s)-2-[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

Ginsenoside C-K is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite, an antineoplastic agent, a hepatoprotective agent, an anti-allergic agent and an anti-inflammatory agent. It is a beta-D-glucoside, a 12beta-hydroxy steroid, a ginsenoside, a tetracyclic triterpenoid, a 3beta-hydroxy steroid and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane. ginsenoside C-K is a natural product found in Panax ginseng and Fusarium sacchari with data available. A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively. Ginsenoside K. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=39262-14-1 (retrieved 2024-10-17) (CAS RN: 39262-14-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

(20R)-Ginsenoside Rh2

2-{[16-hydroxy-14-(2-hydroxy-6-methylhept-5-en-2-yl)-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(20R)-Ginsenoside Rh2 is found in tea. (20R)-Ginsenoside Rh2 is isolated from Panax ginseng (ginseng). Isolated from Panax ginseng (ginseng). Ginsenoside Rh2 is found in tea. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

Squamosinin A

4-[2,13-dihydroxy-13-[5-[5-[5-(1-hydroxyhexyl)oxolan-2-yl]oxolan-2-yl]oxolan-2-yl]tridecyl]-2-methyl-2H-furan-5-one

C36H62O8 (622.4444)

Squamosinin A is found in fruits. Squamosinin A is a constituent of Annona squamosa (sugar apple). Constituent of Annona squamosa (sugar apple). Squamosinin A is found in fruits.

Ginsenoside C-K

2-[(2-{5,16-dihydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl}-6-methylhept-5-en-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

DG(13:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O8 (622.4444)

DG(13:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl tridecanoic acid

C36H62O8 (622.4444)

DG(PGE2/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O8 (622.4444)

DG(13:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O8 (622.4444)

DG(PGE2/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O8 (622.4444)

DG(13:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl tridecanoic acid

C36H62O8 (622.4444)

DG(PGD2/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O8 (622.4444)

DG(13:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O8 (622.4444)

DG(PGD2/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-hydroxy-3-(tridecanoyloxy)propan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C36H62O8 (622.4444)

DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0)

(2S)-3-hydroxy-2-(tridecanoyloxy)propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-hydroxy-3-(tridecanoyloxy)propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C36H62O8 (622.4444)

DG(13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(a-13:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/a-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGE2/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/a-13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGE2/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(a-13:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/a-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGD2/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/a-13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGD2/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C36H62O8 (622.4444)

DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(a-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(i-13:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGE2/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGE2/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(i-13:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGD2/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O8 (622.4444)

DG(PGD2/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C36H62O8 (622.4444)

DG(i-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Ginsenoside Rh10

Pseudoginsenoside Rh2

C36H62O8 (622.4444)

Annotation level-1

Ginsenoside Rh2 (S-FORM)

C36H62O8 (622.4444)

Annotation level-1

Ginsenoside Rh2

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tri

C36H62O8 (622.4444)

20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68[4]. 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68[4]. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

Squamosinin A

3-[2,13-dihydroxy-13-(5-{5-[5-(1-hydroxyhexyl)oxolan-2-yl]oxolan-2-yl}oxolan-2-yl)tridecyl]-5-methyl-2,5-dihydrofuran-2-one

C36H62O8 (622.4444)

20(S)-Ginsenoside Rh2

C36H62O8 (622.4444)

DG(13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(PGE2/13:0/0:0)

C36H62O8 (622.4444)

DG(13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(PGE2/0:0/13:0)

C36H62O8 (622.4444)

DG(13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(PGD2/13:0/0:0)

C36H62O8 (622.4444)

DG(13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(PGD2/0:0/13:0)

C36H62O8 (622.4444)

DG(a-13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(PGE2/a-13:0/0:0)

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(PGE2/0:0/a-13:0)

C36H62O8 (622.4444)

DG(a-13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(PGD2/a-13:0/0:0)

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(PGD2/0:0/a-13:0)

C36H62O8 (622.4444)

DG(i-13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(PGE2/i-13:0/0:0)

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(PGE2/0:0/i-13:0)

C36H62O8 (622.4444)

DG(i-13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(PGD2/i-13:0/0:0)

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(PGD2/0:0/i-13:0)

C36H62O8 (622.4444)

DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0)

C36H62O8 (622.4444)

DG(13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/13:0)

C36H62O8 (622.4444)

DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0)

C36H62O8 (622.4444)

DG(a-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-13:0)

C36H62O8 (622.4444)

DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0)

C36H62O8 (622.4444)

DG(i-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-13:0)

C36H62O8 (622.4444)

20(R)-Ginsenoside-Rh2

20(r)-ginsenoside-rh2

C36H62O8 (622.4444)

{"Ingredient_id": "HBIN003464","Ingredient_name": "20(R)-Ginsenoside-Rh2","Alias": "20(r)-ginsenoside-rh2","Ingredient_formula": "C36H62O8","Ingredient_Smile": "CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C","Ingredient_weight": "622.9 g/mol","OB_score": "6.543197059","CAS_id": "NA","SymMap_id": "SMIT11998;SMIT15578","TCMID_id": "8435","TCMSP_id": "MOL011043","TCM_ID_id": "NA","PubChem_id": "54580480","DrugBank_id": "NA"}

20(s)-ginsenosiderh2

20(s)-ginsenoside-rh2

C36H62O8 (622.4444)

{"Ingredient_id": "HBIN003507","Ingredient_name": "20(s)-ginsenosiderh2","Alias": "20(s)-ginsenoside-rh2","Ingredient_formula": "C36H62O8","Ingredient_Smile": "CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C","Ingredient_weight": "622.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15579;SMIT19217","TCMID_id": "8436;31041","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706655","DrugBank_id": "NA"}

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r)-2,6,6-trimethyloxan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r)-2,6,6-trimethyloxan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

3,7,11,15-tetrahydroxy-17-[3-hydroxy-2,4,6-trimethyl-6-(2-methylbutyl)oxan-2-yl]-2,4,6,10,14,16-hexamethylheptadeca-4,8,12,16-tetraenoic acid

C36H62O8 (622.4444)

2-[(8,11-dihydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(2s,3r,4r,5s,6r)-2-{[(3s,4s,7e)-1-[(2r,3r)-3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3-methyloxiran-2-yl]-4-hydroxy-4,8,12-trimethyltrideca-7,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(2s,3s,4s,5s,6r)-2-{[(7e)-1-{3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3-methyloxiran-2-yl}-4-hydroxy-4,8,12-trimethyltrideca-7,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

2-({1-[3-(4,8-dimethylnona-3,7-dien-1-yl)-3-methyloxiran-2-yl]-4-hydroxy-4,8,12-trimethyltrideca-7,11-dien-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

2-[(2-{7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-en-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

2-{[(1s,3ar,3br,7s,9ar,9br,11r)-11-hydroxy-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

2-({5-[2-(3,7-dihydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-1,4,4,6-tetramethyl-2,3,3a,5,8,8a-hexahydroazulen-1-yl}oxy)-6-methyloxane-3,4,5-triol

C36H62O8 (622.4444)

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,11s,12s,12as,12br,14ar,14br)-11-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8s,8as,11s,12s,12as,12br,14ar,14br)-8,11-dihydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9bs,11r,11ar)-11-hydroxy-1-[(2r)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9bs,11r,11ar)-11-hydroxy-1-[(2r)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

2-{[11-hydroxy-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

2-{[11-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(2s,3r,4r,5r,6s)-2-{[(1r,3ar,5s,8ar)-5-{2-[(3r,5ar,6r,7s,9ar)-3,7-dihydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-1,4,4,6-tetramethyl-2,3,3a,5,8,8a-hexahydroazulen-1-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-{[(1r,3ar,5s,8ar)-5-{2-[(3r,5ar,6r,7s,9ar)-3,7-dihydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-1,4,4,6-tetramethyl-2,3,3a,5,8,8a-hexahydroazulen-1-yl]oxy}-6-methyloxane-3,4,5-triol

C36H62O8 (622.4444)

(4e,8e,12e,16e)-3,7,11,15-tetrahydroxy-17-[(2s,3r,4s,6r)-3-hydroxy-2,4,6-trimethyl-6-(2-methylbutyl)oxan-2-yl]-2,4,6,10,14,16-hexamethylheptadeca-4,8,12,16-tetraenoic acid

C36H62O8 (622.4444)

PseudoginsenosideRh2

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(Z)-6-hydroxy-6-methylhept-2-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)